Apremilast efficacy and safety in elderly psoriasis patients over a 48-week period.
J Eur Acad Dermatol Venereol
; 34(11): e705-e707, 2020 Nov.
Article
in En
| MEDLINE
| ID: mdl-32277507
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Psoriasis
/
Thalidomide
Limits:
Aged
/
Humans
Language:
En
Journal:
J Eur Acad Dermatol Venereol
Journal subject:
DERMATOLOGIA
/
DOENCAS SEXUALMENTE TRANSMISSIVEIS
Year:
2020
Document type:
Article
Affiliation country:
Italy
Country of publication:
United kingdom